U.S. markets open in 1 hour 57 minutes

Alexion Pharmaceuticals, Inc. (ALXN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
119.67+1.48 (+1.25%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 10/23/2020
Current
6/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
26.23B24.59B19.85B23.93B21.67B
Enterprise Value 3
25.98B24.86B19.77B24.42B22.31B
Trailing P/E
31.9110.608.3916.5916.52
Forward P/E 1
9.9910.798.349.058.27
PEG Ratio (5 yr expected) 1
0.790.830.640.520.46
Price/Sales (ttm)
4.814.754.045.154.92
Price/Book (mrq)
2.502.091.762.312.13
Enterprise Value/Revenue 3
4.6917.2113.6817.6417.67
Enterprise Value/EBITDA 6
28.87-20.0725.3934.1834.55

Trading Information

Stock Price History

Beta (5Y Monthly) 1.35
52-Week Change 313.78%
S&P500 52-Week Change 314.26%
52 Week High 3128.57
52 Week Low 372.67
50-Day Moving Average 3115.95
200-Day Moving Average 3108.96

Share Statistics

Avg Vol (3 month) 32.12M
Avg Vol (10 day) 31.97M
Shares Outstanding 5219.17M
Float 218.56M
% Held by Insiders 10.30%
% Held by Institutions 195.39%
Shares Short (Sep 29, 2020) 45.59M
Short Ratio (Sep 29, 2020) 42.25
Short % of Float (Sep 29, 2020) 42.66%
Short % of Shares Outstanding (Sep 29, 2020) 42.55%
Shares Short (prior month Aug 30, 2020) 44.84M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3May 22, 2011

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin 15.28%
Operating Margin (ttm)46.40%

Management Effectiveness

Return on Assets (ttm)10.27%
Return on Equity (ttm)8.19%

Income Statement

Revenue (ttm)5.54B
Revenue Per Share (ttm)24.97
Quarterly Revenue Growth (yoy)20.10%
Gross Profit (ttm)4.6B
EBITDA 2.91B
Net Income Avi to Common (ttm)846.1M
Diluted EPS (ttm)3.81
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.85B
Total Cash Per Share (mrq)13.01
Total Debt (mrq)2.82B
Total Debt/Equity (mrq)26.87
Current Ratio (mrq)4.79
Book Value Per Share (mrq)47.88

Cash Flow Statement

Operating Cash Flow (ttm)2.46B
Levered Free Cash Flow (ttm)1.69B